Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.11 +0.05 (+83.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Return on Sales [ROS] (2010 - 2011)

Updated

Mosaic ImmunoEngineering (CPMV) posted Return on Sales [ROS] of -1641.83% for Q2 2012, up 751.91 percentage points from -2393.73% a year earlier but down 1043.43 percentage points from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Return on Sales [ROS] (2010 - 2011) Analysis & Trends

For the trailing twelve months through Nov 30, 2011, Return on Sales [ROS] at Mosaic ImmunoEngineering was 214.65%.

  • Quarterly Return on Sales [ROS] has run from a low of -2393.73% in Q2 2011 to a high of -598.40% in Q1 2012 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Mosaic ImmunoEngineering 796,635.07 796,635.07 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 -1,641.83%
Aug 31, 2011 -598.40%
Nov 30, 2010 -2,393.73%
Aug 31, 2010 -1,684.65%
API Access

Mosaic ImmunoEngineering Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CPMV&period=max&api_key=YOUR_API_KEY